Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer

Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy

Wockhardt Hospitals, Mira Road launches training program for family physician

To equip them with the latest knowledge and skills to handle patients coming to them in a better way

Dupixent is now approved in India for the treatment of adults with moderate-to-severe atopic dermatitis

Health Ministry organizes webinar on Non-Alcoholic Fatty Liver Diseases

Health Secretary highlights the need for capacity building programmes for Medical Officers to tackle Non Communicable Diseases at the primary level

Advanced Treatments for Brain Tumors: Secure Procedures Available

Brain Cells are starved of energy when autophagy malfunctions: New Study

The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments

Mandaviya reviews organ donation policy

Organ Transplants triple across the country; rise from 5000 (2013) to more than 15000 in 2022

Sun Pharma launches CEQUA, a novel therapy for Dry Eye Disease in India

CEQUA is the first dry eye treatment available in India that is delivered with nanomicellar (NCELL) technology

Fibe partners with Pristyn Care to power affordable quality healthcare across India

Affordability is key to providing accessible healthcare for Bharat.

DG, ICMR and Director CSIR-NIScPR release special issues of Vigyan Pragati & Science Reporter magazines

Science communication brings behavioural changes